With the progress of GOLPH2 as a promising marker for hepatocellular carcinoma, the novel dual-regulated oncolytic virus GD55 can become an effective anticancer agent candidate for future therapy of human hepatocellular carcinoma. The gene discussed is GOLM1; the disease is hepatocellular carcinoma.